Ascendis Pharma A (ASND) Current Assets (2012 - 2026)

Ascendis Pharma A (ASND) has 15 years of Current Assets data on file, last reported at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 35.56% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 35.56% YoY), and the FY2025 full-year result was $1.3 billion, up 63.95% from the prior year.
• Current Assets advanced to $1.3 billion in Q1 2026, from $1.3 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.3 billion in Q1 2026 to a low of $675.6 million in Q2 2024.
• A 5-year average of $983.7 million and a median of $969.3 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets soared 68.66% in 2022 and slumped 37.81% in 2023, its largest moves.
• Tracing ASND's Current Assets over 5 years: stood at $942.2 million in 2022, then slipped by 19.75% to $756.1 million in 2023, then rose by 2.82% to $777.4 million in 2024, then soared by 66.06% to $1.3 billion in 2025, then gained by 1.79% to $1.3 billion in 2026.
• Business Quant data shows ASND's Current Assets at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.2 billion in Q3 2025.